ACT for Weight-related Experiential Avoidance

Sponsor
Bahcesehir Cyprus University (Other)
Overall Status
Completed
CT.gov ID
NCT05486442
Collaborator
(none)
32
1
2
3
10.7

Study Details

Study Description

Brief Summary

This study aimed to investigate whether Acceptance and Commitment Therapy/Training would be helpful to reduce weight-related experiential avoidance among individuals who reported weight concern

Condition or Disease Intervention/Treatment Phase
  • Behavioral: ACT for weight-related experiential avoidance
N/A

Detailed Description

This quasi-experimental study aimed to examine the efficacy of Acceptance and Commitment Therapy/Training (ACT) in reducing weight-related experiential avoidance. Data were collected with a convenience sampling technique. After obtaining ethical approval, participants were invited to participate in the study via advertisements, and online posts. Due to the small sample size, participants who were willing to attend group discussions were included in the experimental group. Participants in the control group did not receive manipulation. All participants were provided with an informed consent form. All participants completed a questionnaire measuring outcomes (weight-related experiential avoidance, general experiential avoidance, eating attitudes, and social physique anxiety) at pre-test, post-test, and follow-up. Participants in the experimental group received ACT training including 6 sessions. The protocol was adapted from Pearson et al. (2012) with their permission. Each session took approximately 80 mins. Several aspects of ACT approach were discussed in the sessions. In session one, ACT approach was introduced. In session two, creative hopelessness was discussed. In session three, control strategies related to weight concern were identified. In session four, mindfulness exercises were completed. In the fifth session, values for meaningful life experience were discussed. In the last, sixth session, the ways to commit to action were discussed. Each session included exercises and homework. At the end of the study, the participants were provided with debrief form.

Study Design

Study Type:
Interventional
Actual Enrollment :
32 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Acceptance and Commitment Training for Weight-related Experiential Avoidance
Actual Study Start Date :
Mar 4, 2022
Actual Primary Completion Date :
Jun 3, 2022
Actual Study Completion Date :
Jun 3, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental group

Participants in the experimental group received ACT training in the group setting aiming to reduce weight-related experiential avoidance. This included 6 sessions in total. Each session was completed approximately in 80 mins.

Behavioral: ACT for weight-related experiential avoidance
Participants in the experimental group received weight concern-related ACT training in a group setting. Each session focused on different dimensions of ACT and included relevant exercises and homeworks. Dimensions studied included creative hopelessness, control strategies, mindfulness exercises, values and barries to values and commitment to action.

No Intervention: Control group

Participants in the control group did not receive any manipulation

Outcome Measures

Primary Outcome Measures

  1. Change in weight-related experiential avoidance [At three time points (pre-intervention [baseline], immediately after the intervention, and at three weeks after the intervention)]

    It was measured by Acceptance and Action Questionnaire for Weight-Related Difficulties-Revised. The scale includes 10 items that are rated on 7 points scale (1 = not true at all - 7 = completely true). Higher scores indicate greater weight related experiential avoidance.

Secondary Outcome Measures

  1. Change in eating attitudes [At three time points (pre-intervention [baseline], immediately after the intervention, and at three weeks after the intervention)]

    Eating attitudes were measured by The Eating Attitudes Test-26. It includes 26 items that are rated on 4 point scale ('3 = Always, 2 = Usually, 1 = Often, 0 = Sometimes, Rarely, and Never'). The last item (26) requires reverse coding. Scores 20 and above indicate dysfunctional eating attitudes.

  2. Change in general experiential avoidance [At three time points (pre-intervention [baseline], immediately after the intervention, and at three weeks after the intervention)]

    It was measured by Acceptance and Action Questionnaire-II. It includes 7 items that are rated on 7 point scale (1 = never true - 7 = always true). Minimum and maximum scores range between 7 and 49 points. Higher scores indicate greater general experiential avoidance (psychological inflexibility).

  3. Change in social physique anxiety [At three time points (pre-intervention [baseline], immediately after the intervention, and at three weeks after the intervention)]

    It was measured by The Social Physique Anxiety Scale. The scale includes 12 items are rated on a 5-point scale (1=not at all true to 5=extremely true). Higher scores indicate a higher level of anxiety related to the social physique. Only item 1, 2, 5, 8 and 11 requires reverse coding.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Individuals who were 18 years and older

  • Ability to read and understand Turkish

Exclusion Criteria:
  • Individuals who have received mental health intervention over the last one year

  • and those who were diagnosed with an eating disorder were excluded from the analyses

Contacts and Locations

Locations

Site City State Country Postal Code
1 Near East University Nicosia Cyprus

Sponsors and Collaborators

  • Bahcesehir Cyprus University

Investigators

  • Study Director: Meryem Karaaziz, PhD, Near East University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Buse Keskindag, Principal Investigator, Bahcesehir Cyprus University
ClinicalTrials.gov Identifier:
NCT05486442
Other Study ID Numbers:
  • NEU/SS/2022/1208
First Posted:
Aug 3, 2022
Last Update Posted:
Aug 3, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Aug 3, 2022